Research
Adherence
Online marketing of GLP-1 receptor agonists as 'weight loss injections' creates unrealistic expectations and encourages off-label, non-medical use, posing significant public health risks.
Be skeptical of online content that promotes GLP-1 injections as 'weight loss injections' without mentioning medical indications, side effects, or the need for a prescription. These are serious medications for obesity management, not cosmetic shortcuts. Consult a healthcare provider to determine if you are a suitable candidate and to understand the risks and benefits.
ModerateRefutesMEDIUM confidence
However, these agents are frequently presented in media using simplified and misleading terminology such as 'weight loss injections,' which may create unrealistic expectations and encourage inappropriate or off-label use.
Why this rating
Qualitative content analysis of web pages; observational, not experimental.
Source
A Content Analysis of Web Pages on “Weight-Loss Injections”
Asuman Okur · Cerasus journal of medicine. · 2026
DOI 10.70058/cjm.1852434
cross_sectional · n=44
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Adherence
- Regular physical activity (at least 150 minutes/week of moderate-intensity) reduces all-cause and cardiovascular mortality by 20-30% and lowers the risk of type 2 diabetes by 25-35%.Strong
- Increasing physical activity from a sedentary lifestyle to an active one in middle adulthood significantly reduces the risk of coronary events compared to remaining sedentary.Strong
- Resistance exercise is the only intervention capable of consistently restoring muscle function and strength in sarcopenia, partially overcoming age-related anabolic resistance.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →